Michael R. Minogue - 30 Sep 2021 Form 4 Insider Report for ABIOMED INC

Role: Chairman, President, CEO, Director
Signature: /s/ Marc A Began (by power of attorney)
Issuer symbol: N/A
Transactions as of: 30 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 04 Oct 2021, 17:19:45 UTC
Previous filing: 25 Aug 2021
Next filing: 05 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABMD	Common Stock $.01 par value	Award	$0	+36	+0.02%	$0.000000	211,671	30 Sep 2021	Direct	F4
holding	ABMD	Common Stock $.01 par value						52,555	30 Sep 2021	By Trust - A
holding	ABMD	Common Stock $.01 par value						73,745	30 Sep 2021	By Trust - B
holding	ABMD	Common Stock $.01 par value						32,810	30 Sep 2021	By Trust - C
holding	ABMD	Common Stock $.01 par value						655	30 Sep 2021	By Trust - D
holding	ABMD	Common Stock $.01 par value						38,560	30 Sep 2021	By Trust - E
holding	ABMD	Common Stock $.01 par value						85,040	30 Sep 2021	By Trust - F

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ABMD	Stock Option (right to buy)						85,000	30 Sep 2021	Common Stock	0	$21.55	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						35,000	30 Sep 2021	Common Stock	0	$66.25	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						30,500	30 Sep 2021	Common Stock	0	$99.62	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						33,000	30 Sep 2021	Common Stock	0	$134.51	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						30,000	30 Sep 2021	Common Stock	0	$381.97	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						50,000	30 Sep 2021	Common Stock	0	$266.39	Direct	F2, F3
holding	ABMD	Stock Option (Right to Buy)						20,898	30 Sep 2021	Common Stock	0	$223.90	Direct	F2, F3
holding	ABMD	Stock Option (Right to Buy)						30,000	30 Sep 2021	Common Stock	0	$283.88	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F2	These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F3	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F4	These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c).